Bibliography
- Folk JE , ChungSI: Molecular and catalytic properties of transglutaminases.Adv. Enzymol.38, 109–191 (1973).
- Lorand L , GrahamRM: Transglutaminases: crosslinking enzymes with pleiotropic functions.Nat. Rev. Mol. Cell. Biol.4, 140–156 (2003).
- Grant FJ , TaylorDA, SheppardPOet al. : Molecular cloning and characterization of a novel transglutaminase cDNA from a human prostate cDNA library.Biochem. Biophys. Res. Commun.203, 1117–1123 (1994).
- Ho KC , QuarmbyVE, FrenchFS, WilsonEM: Molecular cloning of rat prostate transglutaminase complementary DNA. The major androgen-regulated protein DP1 of rat dorsal prostate and coagulating gland.J. Biol. Chem.267, 12660–12667 (1992).
- Gentile V , GrantFJ, PortaR, BaldiniA: Localization of the human prostate transglutaminase (type IV) gene (TGM4) to chromosome 3p21.33-p22 by fluorescence in situ hybridization.Genomics27, 219–220 (1995).
- Dubbink HJ , de Waal L, van Haperen R, Verkaik NS, Trapman J, Romijn JC: The human prostate-specific transglutaminase gene (TGM4): genomic organization, tissue-specific expression, and promoter characterization. Genomics51, 434–444 (1998).
- Dubbink HJ , VerkaikNS, FaberPW, TrapmanJ, SchroderFH, RomijnJC: Tissue-specific and androgen-regulated expression of human prostate-specific transglutaminase.Biochem. J.315, 901–908 (1996).
- Dubbink HJ , HoedemaekerRF, van der Kwast TH, Schroder FH, Romijn JC: Human prostate-specific transglutaminase: a new prostatic marker with a unique distribution pattern. Lab. Invest.79, 141–150 (1999).
- Wilson EM , FrenchF: Biochemical homology between rat dorsal prostate and coagulating gland. Purification of a major androgen-induced protein.J. Biol. Chem.255, 10946–10953 (1980).
- Hayashi N , SugimuraY, KawamuraJ, DonjacourAA, CunhaGR: Morphological and functional heterogeneity in the rat prostatic gland.Biol. Reprod.24, 24–32 (1981).
- Williams-Ashman HG : Transglutaminases and the clotting of mammalian seminal fluids.Mol. Cell. Biochem.58, 51–61 (1984).
- Ablin RJ , WhyardT: Identification and biological relevance of spermatozoal transglutaminase.Experientia47, 277–279 (1991).
- Ablin RJ , BartkusJM, GonderMJ, PolgarJ: Factors contributing to suppression of tumor-host responsiveness. In: Human Tumor Markers-Biology and Clinical Applications. CiminoF, BirkmayerCD, PimentalE, KlavinsJV, de GruyterSFW (Eds). Berlin, Germany, 279–299 (1987).
- Ablin RJ , BartkusJM, PolgarJ: Effect of human seminal plasma on the lytic activity of natural killer cells and presumptive identification of participant macromolecules.Am. J. Reprod. Immunol.24, 15–21 (1990).
- Whyard TC , AblinRJ: A tissue type transglutaminase in human seminal plasma.Amer. J. Reprod. Immunol.38, 391–399 (1997).
- Ablin RJ , GonderMJ: Male accessory sexual glands secretions and their antithetical role in immunosurveillance. In: Protides of the Biological Fluids. Peeters H (Ed.). Pergamon Press Ltd, Oxford, UK, 271–276 (1985).
- Davies G , AblinRJ, MasonMD, JiangWG: Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.J. Exp. Therapeut. Oncol.6, 257–264 (2007).
- Jiang WG , AblinR, Douglas-JonesA, ManselRE: Expression of transglutaminases and the clinical significance in human breast cancer.Oncology Rep.10, 2039–2044 (2003).
- Prins GS , WoodhamC, LepinskeM, BirchL: Effects of neonatal estrogen exposure on prostatic secretory genes and their correlation with androgen receptor expression in the separate prostate lobes of the adult rat.Endocrinology132, 2387–2398 (1993).
- An G , MekaCS, BrightSP, VeltriRW: Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression,and down-regulation in metastatic prostate cancer.Urology54, 1105–1111 (1999).
- Birckbichler PJ , BonnerRB, HurstRE, BaneBL, PithaJV, HemstreetGP 3rd: Loss of tissue transglutaminase as a biomarker for prostate adenocarcinoma. Cancer89, 412–423 (2000).
- Jiang WG , AblinRJ, KynastonHG, MasonMD: Expression of the prostate type transglutaminase (TGase-4) in clinical prostate cancer (Abstract). Presented at: American Association for Cancer Research, 98th Annual Meeting. Los Angeles, CA, USA, 14–18 April 2007.
- Cho SY , ChoiK, JeonJH, KimCWet al. : Differential alternative splicing of human transglutaminase 4 in benign prostate hyperplasia and prostate cancer.Exp. Mol. Med.42, 310–318 (2010).
- Cho SY , JeonJH, KimCWet al. : Monoclonal antibodies to human transglutaminase 4.Hybridoma (Larchmt.)29, 263–267 (2010).
- Ablin RJ , WhyardTC: Immunobiological implications of select bioactive molecules in the prostate with a known and and unknown target. In: The Prostate as an Endocrine Gland. FarnsworthWE, AblinRJ (Eds). CRC Press, Inc., Boca Raton, FL, USA, 149–172 (1990).
- Koivisto P , KolmerM, VisakorpiT, KallioniemiOP: Androgen receptor gene and hormonal therapy failure of prostate cancer.Am. J. Pathol.152, 1–9 (1998).
- Trapman J , CleutjensKB: Androgen-regulated gene expression in prostate cancer.Semin. Cancer Biol.8, 29–36 (1997).
- Cude KJ , DixonSC, GuoY, LisellaJ, FiggWD: The androgen receptor: genetic considerations in the development and treatment of prostate cancer.J. Mol. Med.77, 419–426 (1999).
- Jiang WG , YeL, AblinRJ, KynastonHG, MasonMD: The prostate transglutaminase, TGase-4, coordinates with the HGFL/MSP-RON system in stimulating the migration of prostate cancer cells.Int. J. Oncol.37, 413–418 (2010).
- Jiang WG , AblilnRJ, MasonMD: The impact of prostate transglutaminase (TGase-4) on the micromotion of prostate cancer cells. Presented at: 2010 Genitourinary Cancers Symposium. San Francisco, CA, USA, 5–7 March 2010.
- Jiang WG , AblinRJ, KynastonHG, MasonMD: The prostate transglutaminase (TGase-4) impacts the cell-matrix adhesion of prostate cancer cells, an electric cell-substrate sensing study. Presented at: American Society for Cell Biology, 47th Annual Meeting. Washington, DC, USA, 1–5 December 2007.
- Jiang WG , AblinR: Expression of transglutaminase in human prostate cancer cells and the role in motogen induced migration and matrix adhesion.FASEB J.17, C288 (2003).
- Boyer B , ThieryJP: Epithelium-mesenchyme interconversion as example of epithelial plasticity. APMIS 101, 257–268 (1993).
- Mathias RA , SimpsonRJ: Towards understanding epithelial-mesenchymal transition: a proteomics perspective.Biochim. Biophys. Acta.1794, 1325–1331 (2009).
- Thiery JP , AcloqueH, HuangRY, NietoMA: Epithelial-mesenchymal transitions in development and disease.Cell139, 871–890 (2009).
- Iwatsuki M , MimoriK, YokoboriTet al. : Epithelial-mesenchymal transition in cancer development and its clinical significance.Cancer Sci.101, 293–299 (2009).
- Shao M , CaoL, ShenCet al. : Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase.Cancer Res.69, 9192–9201 (2009).
- Ablin RJ , JiangWG: Prostate transglutaminase (TGase-4) induces epithelial-mesenchymal transition (EMT) in prostate cancer cells. Presented at: 4th International Conference Epithelial–Mesenchymal Transition. Tucson, AZ, USA, 23–28 September 2008.
- Nicolson GL , BirdwellCR, BrunsonKW, RobbinsJC: Cellular interactions in the metastatic process.Prog. Clin. Biol. Res.9, 237–244 (1976).
- Alonso-Varona A , PalomaresT, BilbaoP, CalleY, CastroB, Barberá-GuillemE: Tumor–host interaction in non-random metastatic pattern distribution.Bull. Cancer83, 27–38 (1996).
- Iiizumi M , MohintaS, BandyopadhyayS, WatabeK: Tumor–endothelial cell interactions: therapeutic potential.Microvasc. Res.74, 114–120 (2007).
- Jiang WG , AblinRJ, KynastonHG, MasonMD: The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway.Microvasc. Res.77, 150–157 (2009).
- Emdad L , LebedevaIV, SuZ-Zet al.: Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24.Cancer Biol. Therapy8, 391–400 (2009).
- Saito Y , MiyaharaR, GopalanBet al. : Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated-7 (MDA-7)/interleukin-24 (IL-24) gene.Cancer Gene Ther.12, 238–247 (2005).
- Ablin RJ , KynastonHG, MasonMD, JiangWG: Prostate type transglutaminase (TGase-4) antagonizes the anti-tumor action of MDA-7/IL-24 in prostate cancer.J. Transl. Med.9, 49 (2011).
- Han S , StuartLA, DegenSJF: Characterization of the DNF15S2 locus on human chromosome 3: identification of a gene coding for four kringle domains with homology to hepatocyte growth factor.Biochemistry30, 9768–9780 (1991).
- Ronsin C , MuscatelliF, MatteiMG, BreathnachR: A novel putative receptor protein tyrosine kinase of the met family.Oncogene8, 1195–1202 (1993).
- Welm AL , SneddonJB, TaylorCet al. : The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans.Proc. Natl Acad. Sci. USA104, 7570–7575 (2007).
- Sakamoto O , IwamaA, AmitaniRet al. : Role of macrophage-stimulating protein and its receptor, RON tyrosine kinase, in ciliary motility.J. Clin. Invest.99, 701–709 (1997).
- Davies G , WatkinsG, SandersAJet al. : A hammerhead ribozyme transgene to transglutaminase-4 increases the level of its substrate psoriasin and reduces the invasive capacity of prostate cancer cells in vitro. Presented at: American Association for Cancer Research, 96th Annual Meeting, Anaheim, CA, USA, 16–20 April 2005.
- Madsen P , RasmussenHH, LeffersHet al. : Molecular cloning, occurrence, and expression of a novel partially secreted protein ‘psoriasin‘ that is highly up-regulated in psoriatic skin.J. Invest. Dermatol.97, 701–712 (1991).
- Rautiainen J , RytkonenM, ParkkinenSet al. : cDNA cloning and protein analysis of a bovine dermal allergen with homology to psoriasin.Invest. Dermatol.105, 660–663 (1995).
- Watson PH , LeygueER, MurphyLC: Psoriasin (S100A7).Int. J. Biochem. Cell. Biol.30, 567–571 (1998).
- Alowami S , QingG, EmberleyE, SnellL, WatsonPH: Psoriasin (S100A7) expression is altered during skin tumorigenesis.BMC Dermatol.3, 1 (2003).
- Moog-Lutz C , BouilletP, RegnierCHet al. : Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22.Int. J. Cancer63, 297–303 (1995).
- Jiang WG , WatkinsG, Douglas-JonesA, ManselRE: Psoriasin is aberrantly expressed in human breast cancer and is related to clinical outcomes.Int. J. Oncol.25, 81-85 (2004).
- Ruse M , LambertA, RobinsonN, RyanD, ShonKJ, EckertRL: S100A7, S100A10, and S100A11 are transglutaminase substrates.Biochemistry40, 3167–3173 (2001).